Jane Street Group, LLC Genprex, Inc. Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.32 - $58.0 $26,303 - $1.16 Million	19,927 New	19,927 $28,000
Q2 2022 Aug 16, 2022	SELL	$1.28 - $2.31 $15,616 - $28,182	-12,200 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$1.82 - $3.5 $22,204 - $42,700	12,200 New	12,200 $28,000
Q3 2021 Nov 16, 2021	SELL	$2.59 - $3.36 $62,867 - $81,557	-24,273 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.11 - $4.87 $24,593 - $38,511	7,908 Added 48.32%	24,273 $81,000
Q1 2021 May 18, 2021	BUY	$3.66 - $7.67 $59,895 - $125,519	16,365 New	16,365 $71,000
Q3 2020 Nov 17, 2020	SELL	$2.9 - $4.29 $148,975 - $220,381	-51,371 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$1.99 - $3.64 $81,629 - $149,312	41,020 Added 396.29%	51,371 $161,000
Q1 2020 May 15, 2020	BUY	$0.28 - $6.23 $2,898 - $64,486	10,351 New	10,351 $25,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $39.9M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.